Carol Wrenn files SEC Form 4 disclosures for ALPHARMA INC. They have made 6 open-market trades across 3 companies since 2006, most recently 2018-05-03.
CIK 0001196058
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $52K since 2013, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HSKA | SELL | 2017-05-23 | 2017-05-25 | $96.94 | $248K | -4.1% | -1.0% | +2.3% |
| PAHC | BUY | 2014-04-16 | 2014-04-16 | $16.19 | $16K | -5.6% | -1.7% | -1.7% |
| HSKA | BUY | 2014-03-31 | 2014-04-02 | $10.50 | $11K | -7.8% | -2.5% | -2.5% |
| HSKA | BUY | 2013-03-01 | 2013-03-05 | $8.33 | $25K | -7.8% | -2.5% | -2.5% |
| ALO | SELL | 2007-05-17 | 2007-05-18 | $23.28 | $166K | N/A | N/A | N/A |
| ALO | SELL · 10b5-1 | 2007-02-01 | 2007-02-02 | $28.00 | $1.2M | N/A | N/A | N/A |
| ALO | SELL · 10b5-1 | 2006-07-18 | 2006-07-18 | $21.60 | $210K | N/A | N/A | N/A |
| ALO | SELL · 10b5-1 | 2006-05-12 | 2006-05-16 | $24.62 | $308K | N/A | N/A | N/A |
| ALO | SELL | 2006-03-17 | 2006-03-20 | $27.23 | $980K | N/A | N/A | N/A |
| ALO | SELL · 10b5-1 | 2006-01-27 | 2006-01-27 | $33.02 | $358K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.